Microsoft PowerPoint - AVNT M8 Investor Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) AU G U S T 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 3 AVIENT OVERVIEW 2023 Financial ResultsCompany Overview Revenue By: 9,300 Employees 102 Manufacturing Sites 20,000+ Customers  Innovating materials and processing solutions to solve our customers’ challenges while enabling a sustainable world  Broad portfolio of technologies with market leading positions and flexibility to anticipate and meet customer needs  Focus is on organic revenue growth and margin expansion, following our successful portfolio transformation $3.14B Revenue $2.36 Adjusted EPS $502M Adjusted EBITDA 16.0% Adjusted EBITDA Margins $186M Adjusted Free Cash Flow U.S. & Canada EMEA Asia Latin America 64% 36% Specialty Engineered Materials Color Additives and Inks 41% 36% 18% 5% 7% 7% 23% 19% 9% 16% 10% 5% 4% Defense Healthcare Packaging Consumer Building & Construction Industrial Transportation Energy Telecom Geography Segment Industry 2024 Financial Guidance $515 to $540 million Adjusted EBITDA $2.55 to $2.70 Adjusted EPS 4 Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile Avient CDP Score: A- SUSTAINABILITY PERFORMANCE AND RECOGNITION AU G U S T 6 , 20 24 W EB CAS T P RE SE N TATI O N 6 Q2 2024 HIGHLIGHTS • 5% organic sales growth supported by broad-based growth across all regions in both CAI and SEM segments • Growth stemmed from gaining share, winning new product specifications and restocking in certain end markets • Cost control and operational discipline expanded EBITDA margins by 100 bps • EPS exceeded guidance by $0.05 and increased 21% vs the prior year Adj.

SILCOGUM BLACK 016 SILCOGUM BLACK 036 PP FR 8-6 LMS-1000

PREC BLACK 8% PREC BLACK 10% PP FR 8-6 LMS-1000

MC-84631PETG BLACK/BLACK MC-87057PP BLACK PP FR 8-6 LMS-1000

在很宽的频率范围仍保持稳定的射频性能 0,0 2,0 4,0 6,0 8,0 10,0 12,0 0 10 20 30 40 50 60 D ie le ct ri c co ns ta nt F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 生产过程中批次间的稳定性 * 2018 年芬兰有限公司VTT技术研究中心测量数据 介 电 常 数 损 耗 因 数 介 电 常 数 频率 [GHz] 频率 [GHz] 分批编号 （1250 kg/批次） PREPERM™ PPE950 PREPERM™ PPE800 PREPERM™ PPE440 PREPERM™ PPE320 PREPERM™ PPE260 -- 目标介电常数 -- +/- 2% 3,76 3,78 3,80 3,82 3,84 3,86 3,88 3,90 3,92 3,94 0 1 2 3 4 5 6 7 8 D ie le ct ri c co ns ta nt P a llet number (1250 k g/pa llet ) Die le ctric cons ta nt ta rge t +/- 2 % 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 0,000 0,002 0,004 0,006 0,008 0,010 0 10 20 30 40 50 60 Lo ss t a ng en t F requency [GHz ] PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0 PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0 PR E PE RM® PPE 26 0 1.844.4AVIENT www.avient.com 版权所有©2022 埃万特公司。

主要特性 生产符合高于CAS编号级别的变更控制原则 （与MEVOPUR母粒类似），降低变更风险 不含动物源性物质和邻苯二甲酸盐 适用于吹膜、注塑、吹塑和挤出 • • • 注册药品主文件（III型） 食品接触符合FDA/EU*要求 法规支持 原材料根据以下法规测试： - ISO 10993-1 - USP第、章，包括VI级别，符合眼 科和鼻腔用药物要求 - 欧洲药典3.1.3/3.1.5（聚烯烃） - 美国药典（聚乙烯） - ICH Q3D 杂质元素 - USP和USP，透光率 • • • 载体材料 耐光性 热稳定性 产品代码颜料含量/类型 HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 适用医疗保健使用限制—见下文。

主要特性 可用于聚乙烯、聚丙烯、ABS、聚碳酸酯和苯 乙烯 树脂载体的生物含量从70%到100%不等，具 体取决于聚合物⸺按照ASTM D6866标准计 算 由四家通过ISO 13485认证的工厂生产，稳定 的供应链覆盖全球，品质始终如一 变更控制记录的级别高于CAS编号级别，降低 变更风险 可以像加工化石基聚合物般在普通注塑机和挤 出设备上进行产品加工的嵌入式解决方案 可以以即用型预着色或添加剂配方的形式提供 • • • • • • 法规支持 原材料根据以下标准检测： - ISO 10993-1 - 美国药典和（包括VI类） - 欧洲药典，各论3.1.3/3.1.5（聚烯烃包装材 料） - 美国药典（聚乙烯） - 杂质元素符合ICH Q3D要求 注册药品管理档案（III类）和/或器械主文件 食品接触声明符合美国FDA和EU规范 • • • 适用医疗保健使用限制—见下文。

REP A NR 2394/2011 NOTARIUSZ ANNA KOPCZYŃSKA KANCELARIA NOTARIALNA W ŁODZI - ZMIANA §§ 4, 7, 8, 9, 11 UST.2 PKT G; NOWY § 11 UST.2 PKT H; ZMIANA NUMERACJI PKT-ÓW: H,I,J,K,L W § 11 UST.2 NA PKT:I,J,K,L,M; ZMIANA § 11 UST.2 I 5, ZMIANA NR §11A NA § 12 I ODPOWIEDNIA ZMINA NUMERACJI KOLEJNYCH PARAGRAFÓW; ZMIANA §§: 12, 13 UST.1,2,4,5; USUNIĘCIE § 13 UST.6; ZMIANA § 14 UST.2 I § 15; USUNIĘCIE § 16 UST.2, § 18 UST.1 UMOWY SPÓŁKI 4 11.06.2012R.

SILCOGUM BLACK 095 SILCOGUM BLACK 223 PP FR 8-6 LMS-1000

BLACK NEP V2 BLACK NEP V3 PP FR 8-6 LMS-1000